Campbell & Co Investment Adviser’s Cross Country Healthcare CCRN Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37,391	Closed	-$835K	–	905
2023 Q1	$835K	Sell	37,391 -2,070	-5%	-$54.2K	0.16%	223
2022 Q4	$1.05M	Buy	39,461 +4,274	+12%	+$139K	0.25%	85
2022 Q3	$998K	Sell	35,187 -22,941	-39%	-$590K	0.23%	130
2022 Q2	$1.21M	Buy	58,128 +17,704	+44%	+$332K	0.33%	49
2022 Q1	$876K	Buy	40,424 +9,008	+29%	+$195K	0.24%	104
2021 Q4	$872K	Sell	31,416 -1,100	-3%	-$26.7K	0.3%	81
2021 Q3	$691K	Sell	32,516 -4,000	-11%	-$75K	0.23%	131
2021 Q2	$603K	Buy	36,516 +3,900	+12%	+$59.5K	0.25%	112
2021 Q1	$407K	Buy	32,616 +19,080	+141%	+$202K	0.25%	139
2020 Q4	$120K	Buy	+13,536	New	+$110K	0.07%	391
2020 Q1	–	Sell	-16,983	Closed	-$197K	–	96
2019 Q4	$197K	Buy	+16,983	New	+$192K	0.06%	596
2018 Q1	–	Sell	-12,133	Closed	-$155K	–	382
2017 Q4	$155K	Buy	+12,133	New	+$160K	0.11%	344
2017 Q2	–	Sell	-10,929	Closed	-$157K	–	327
2017 Q1	$157K	Buy	+10,929	New	+$161K	0.41%	122

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

SCM

Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Campbell & Co Investment Adviser's CCRN Position: Q2 2023 in Review

Campbell & Co Investment Adviser sold out of Cross Country Healthcare (CCRN) in Q2 2023, closing a stake of 37,391 shares — an estimated $835K sold.

Campbell & Co Investment Adviser first reported a position in CCRN in Q1 2017 and held it in 13 quarters. The position peaked at $1.21M in Q2 2022. 194 funds tracked by Wall St. Rank hold CCRN as of Q2 2023.

Campbell & Co Investment Adviser reported no remaining Cross Country Healthcare position as of Q2 2023 after selling out during the quarter.
Campbell & Co Investment Adviser sold 37,391 Cross Country Healthcare shares in Q2 2023, an estimated $835K.
Campbell & Co Investment Adviser first reported a position in Cross Country Healthcare in Q1 2017 and held it in 13 quarters.
Campbell & Co Investment Adviser's Cross Country Healthcare position peaked at $1.21M in Q2 2022.
194 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2023.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2023, filed 11 Aug 2023.